This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lupin, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Joseph Amprey: Innovator in Pharmaceutical Formulations
Introduction
Joseph Amprey is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial vaginosis. His innovative work has led to the development of novel formulations that enhance treatment efficacy.
Latest Patents
Joseph Amprey holds a patent for "Secnidazole formulations and use in treating bacterial vaginosis." This patent describes pharmaceutical compositions that comprise a plurality of microgranules containing nitroimidazole compounds. These compositions are designed for effective treatment of bacterial vaginosis, showcasing Amprey's commitment to advancing medical science.
Career Highlights
Amprey is currently associated with Lupin, Inc., a prominent pharmaceutical company. His role at Lupin has allowed him to focus on developing innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of pharmaceutical sciences.
Collaborations
Some of his notable coworkers include David Palling and Ronald S. Vladyka. Their collaborative efforts have further enriched the research environment at Lupin, fostering innovation and development in pharmaceutical formulations.
Conclusion
Joseph Amprey's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of bacterial vaginosis, highlight the importance of research and development in improving healthcare outcomes.